Bioassay of EDRFs released from rat mesenteric resistance arteries

G. J. Waldron, H. Donc, D. Galipeau, W. C. Cole, Christopher Triggle

Research output: Contribution to journalArticle

Abstract

Nitric oxide released from endothelial cells has been bioassayed previously, though EDHF, which differs from nitric oxide, has only recently been convincingly bioassayed. These studies, however, were performed in large conduit arteries. We wished to investigate whether these compounds could be bioassayed in resistance arteries. Rat small mesenteric arteries were set up in a dual chamber pressure myograph at 60 mm Hg, perfused at 100 ul/min and their lumen diameters measured by video-microscopy. Values given are the mean ±SEM of 5-6 vessels. The arteries had a mean diameter, when unstimulated, of 275 ±11 jam. When constricted with phenylephrine, acetylcholine (ACh) induced a vasodilation which was insensitive to the nitric oxide synthase inhibitor L-NAME (100 fiM) or indomethacin but was abolished by L-NAME in combination with 25 mM external K+ but not tetrabutylammonium (1 mM). To study the nature of the transferable relaxing factor, two vessels were set up in tandem and the endothelium of the downstream vessel was removed and confirmed by lack of vasodilation to ACh (1 uM; contraction of 2 ±2%). When ACh was added to the upstream, endothelium-intact vessel, both this and the downstream, endothelium-denuded, vessel increased in diameter by 70 ±5 and 30 ±2% of the induced tone, respectively. This indicates that EDRF(s) can be bioassayed from resistance arteries and that the EDHF in this artery may be different to that of rabbit carotid artery which is sensitive to tetrabutylammonium (Dong, Waldron, Galipeau, Cole and Triggle. Brit. J. Pharma-col. in press).

Original languageEnglish
Pages (from-to)160
Number of pages1
JournalProceedings of the Western Pharmacology Society
Volume40
Publication statusPublished - 1997
Externally publishedYes

Fingerprint

Mesenteric Arteries
Biological Assay
Arteries
Acetylcholine
Endothelium
NG-Nitroarginine Methyl Ester
Vasodilation
Nitric Oxide
Video Microscopy
Phenylephrine
Carotid Arteries
Nitric Oxide Synthase
Indomethacin
Endothelial Cells
Rabbits
Pressure

ASJC Scopus subject areas

  • Pharmacology

Cite this

Bioassay of EDRFs released from rat mesenteric resistance arteries. / Waldron, G. J.; Donc, H.; Galipeau, D.; Cole, W. C.; Triggle, Christopher.

In: Proceedings of the Western Pharmacology Society, Vol. 40, 1997, p. 160.

Research output: Contribution to journalArticle

@article{a84816b4d0b94ef2bc0df630419336d7,
title = "Bioassay of EDRFs released from rat mesenteric resistance arteries",
abstract = "Nitric oxide released from endothelial cells has been bioassayed previously, though EDHF, which differs from nitric oxide, has only recently been convincingly bioassayed. These studies, however, were performed in large conduit arteries. We wished to investigate whether these compounds could be bioassayed in resistance arteries. Rat small mesenteric arteries were set up in a dual chamber pressure myograph at 60 mm Hg, perfused at 100 ul/min and their lumen diameters measured by video-microscopy. Values given are the mean ±SEM of 5-6 vessels. The arteries had a mean diameter, when unstimulated, of 275 ±11 jam. When constricted with phenylephrine, acetylcholine (ACh) induced a vasodilation which was insensitive to the nitric oxide synthase inhibitor L-NAME (100 fiM) or indomethacin but was abolished by L-NAME in combination with 25 mM external K+ but not tetrabutylammonium (1 mM). To study the nature of the transferable relaxing factor, two vessels were set up in tandem and the endothelium of the downstream vessel was removed and confirmed by lack of vasodilation to ACh (1 uM; contraction of 2 ±2{\%}). When ACh was added to the upstream, endothelium-intact vessel, both this and the downstream, endothelium-denuded, vessel increased in diameter by 70 ±5 and 30 ±2{\%} of the induced tone, respectively. This indicates that EDRF(s) can be bioassayed from resistance arteries and that the EDHF in this artery may be different to that of rabbit carotid artery which is sensitive to tetrabutylammonium (Dong, Waldron, Galipeau, Cole and Triggle. Brit. J. Pharma-col. in press).",
author = "Waldron, {G. J.} and H. Donc and D. Galipeau and Cole, {W. C.} and Christopher Triggle",
year = "1997",
language = "English",
volume = "40",
pages = "160",
journal = "Proceedings of the Western Pharmacology Society",
issn = "0083-8969",
publisher = "Western Pharmacology Society",

}

TY - JOUR

T1 - Bioassay of EDRFs released from rat mesenteric resistance arteries

AU - Waldron, G. J.

AU - Donc, H.

AU - Galipeau, D.

AU - Cole, W. C.

AU - Triggle, Christopher

PY - 1997

Y1 - 1997

N2 - Nitric oxide released from endothelial cells has been bioassayed previously, though EDHF, which differs from nitric oxide, has only recently been convincingly bioassayed. These studies, however, were performed in large conduit arteries. We wished to investigate whether these compounds could be bioassayed in resistance arteries. Rat small mesenteric arteries were set up in a dual chamber pressure myograph at 60 mm Hg, perfused at 100 ul/min and their lumen diameters measured by video-microscopy. Values given are the mean ±SEM of 5-6 vessels. The arteries had a mean diameter, when unstimulated, of 275 ±11 jam. When constricted with phenylephrine, acetylcholine (ACh) induced a vasodilation which was insensitive to the nitric oxide synthase inhibitor L-NAME (100 fiM) or indomethacin but was abolished by L-NAME in combination with 25 mM external K+ but not tetrabutylammonium (1 mM). To study the nature of the transferable relaxing factor, two vessels were set up in tandem and the endothelium of the downstream vessel was removed and confirmed by lack of vasodilation to ACh (1 uM; contraction of 2 ±2%). When ACh was added to the upstream, endothelium-intact vessel, both this and the downstream, endothelium-denuded, vessel increased in diameter by 70 ±5 and 30 ±2% of the induced tone, respectively. This indicates that EDRF(s) can be bioassayed from resistance arteries and that the EDHF in this artery may be different to that of rabbit carotid artery which is sensitive to tetrabutylammonium (Dong, Waldron, Galipeau, Cole and Triggle. Brit. J. Pharma-col. in press).

AB - Nitric oxide released from endothelial cells has been bioassayed previously, though EDHF, which differs from nitric oxide, has only recently been convincingly bioassayed. These studies, however, were performed in large conduit arteries. We wished to investigate whether these compounds could be bioassayed in resistance arteries. Rat small mesenteric arteries were set up in a dual chamber pressure myograph at 60 mm Hg, perfused at 100 ul/min and their lumen diameters measured by video-microscopy. Values given are the mean ±SEM of 5-6 vessels. The arteries had a mean diameter, when unstimulated, of 275 ±11 jam. When constricted with phenylephrine, acetylcholine (ACh) induced a vasodilation which was insensitive to the nitric oxide synthase inhibitor L-NAME (100 fiM) or indomethacin but was abolished by L-NAME in combination with 25 mM external K+ but not tetrabutylammonium (1 mM). To study the nature of the transferable relaxing factor, two vessels were set up in tandem and the endothelium of the downstream vessel was removed and confirmed by lack of vasodilation to ACh (1 uM; contraction of 2 ±2%). When ACh was added to the upstream, endothelium-intact vessel, both this and the downstream, endothelium-denuded, vessel increased in diameter by 70 ±5 and 30 ±2% of the induced tone, respectively. This indicates that EDRF(s) can be bioassayed from resistance arteries and that the EDHF in this artery may be different to that of rabbit carotid artery which is sensitive to tetrabutylammonium (Dong, Waldron, Galipeau, Cole and Triggle. Brit. J. Pharma-col. in press).

UR - http://www.scopus.com/inward/record.url?scp=33748172924&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33748172924&partnerID=8YFLogxK

M3 - Article

VL - 40

SP - 160

JO - Proceedings of the Western Pharmacology Society

JF - Proceedings of the Western Pharmacology Society

SN - 0083-8969

ER -